Key Takeaway
Understand sermorelin's FDA approval history, why the branded product was discontinued, and how compounded sermorelin is regulated and prescribed today.
Sermorelin was FDA-approved in 1997 under the brand name Geref Diagnostic for evaluating pituitary growth hormone secretion. The branded product was voluntarily discontinued in 2008 for commercial reasons. Today, sermorelin is available through compounding pharmacies as a prescription medication, which operates under a different regulatory framework.
The FDA Approval History
Sermorelin acetate received FDA approval in 1997 for use as a diagnostic agent. The branded product, Geref Diagnostic, manufactured by EMD Serono, was specifically approved for evaluating the ability of the pituitary gland to secrete growth hormone.
Prior to the diagnostic approval, sermorelin had also been marketed under the brand name Geref for therapeutic use in treating growth hormone deficiency in children. This therapeutic indication was available in the early to mid-1990s.
In 2008, EMD Serono voluntarily discontinued the product. The company cited business and commercial reasons for the decision, not safety concerns or efficacy problems. This is an important distinction that we emphasize to our patients: sermorelin was not pulled from the market because it was unsafe. The manufacturer simply chose to stop producing the branded version. is sermorelin legal in the us
What "FDA-Approved" Actually Means
FDA approval means a product has undergone clinical trials demonstrating safety and efficacy for specific indications, and that a particular manufacturer's formulation has met manufacturing standards. It doesn't mean the active ingredient itself becomes illegal or unavailable if the branded product is discontinued.
View data table
| Category | Clinical Interest Score | Detail |
|---|---|---|
| BPC-157 | 88 | Tissue repair and gut healing |
| TB-500 | 82 | Injury recovery |
| Sermorelin | 78 | Growth hormone support |
| Ipamorelin | 75 | Anti-aging and recovery |
| GHK-Cu | 70 | Skin and tissue repair |
When a branded product leaves the market, the underlying drug compound remains part of the medical knowledge base. Providers can still prescribe it, and compounding pharmacies can prepare it under their own regulatory framework. This is exactly what happened with sermorelin.
Compounded Sermorelin: A Different Regulatory Path
Today, most sermorelin used in clinical practice comes from compounding pharmacies. Compounding exists in a distinct regulatory space from commercially manufactured pharmaceuticals:
From the FormBlends catalog
Sermorelin
Bioidentical GHRH analog for natural growth hormone pulsatility · From $175/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Sermorelin →- State pharmacy board oversight: Compounding pharmacies are licensed and regulated by their respective state boards of pharmacy.
- USP standards: Pharmacies must follow United States Pharmacopeia (USP) standards for sterile compounding, specifically USP chapters 795 and 797.
- 503A vs. 503B pharmacies: Section 503A pharmacies compound individual patient prescriptions. Section 503B outsourcing facilities can produce larger batches and are subject to FDA inspection, providing an additional layer of oversight.
- Prescription required: Compounded sermorelin still requires a valid prescription from a licensed provider.
We always recommend that patients verify their compounding pharmacy's accreditation. Pharmacies accredited by the Pharmacy Compounding Accreditation Board (PCAB) have met additional voluntary quality standards. where to buy sermorelin online
Is Off-Label Prescribing Involved?
When a provider prescribes compounded sermorelin for purposes like anti-aging, body composition improvement, or general growth hormone improvement, this is considered off-label use. Off-label prescribing is a common and legal practice in medicine. Physicians routinely prescribe medications for indications beyond their original FDA-approved use when clinical evidence and their medical judgment support doing so.
An estimated 20 to 25 percent of all prescriptions written in the United States are for off-label uses. This practice isn't unique to peptide therapy.
Why This Matters for You
Understanding sermorelin's regulatory status helps you make informed decisions:
- Safety data exists: Sermorelin went through FDA-level clinical evaluation. The safety profile is well-documented from those studies and decades of subsequent clinical use.
- Quality depends on the pharmacy: Since you're receiving a compounded product, the pharmacy's quality standards directly affect what you receive. Choose pharmacies with strong accreditation and transparent practices.
- Provider expertise matters: A knowledgeable provider understands both the evidence supporting sermorelin use and the appropriate monitoring protocols to ensure your safety.
We believe the regulatory picture shouldn't discourage patients from exploring sermorelin. The compound has a long track record, and the compounding framework provides a legitimate pathway to access it. sermorelin research studies
How Sermorelin Compares to Other Peptides Regulatory-Wise
Sermorelin's regulatory history is actually more established than many other peptides used in clinical practice. For context:
- Sermorelin: Former FDA-approved product with clinical trial data
- CJC-1295: No FDA approval history. used based on research literature is cjc-1295 legal in the us
- Ipamorelin: No FDA approval history. used based on research and clinical experience
- BPC-157: No FDA approval. primarily supported by preclinical studies
This comparative advantage gives sermorelin one of the strongest evidence bases among peptides currently used for growth hormone improvement.
Frequently Asked Questions
Was sermorelin removed from the market for safety reasons?
No. The branded product Geref Diagnostic was voluntarily discontinued by the manufacturer in 2008 for commercial and business reasons. There were no safety recalls or FDA enforcement actions involved in the decision.
Is compounded sermorelin as safe as the original FDA-approved product?
The active ingredient is the same. Safety depends on the quality of the compounding pharmacy. Pharmacies that follow USP standards and hold PCAB accreditation produce products that meet high quality and sterility standards. Always verify your pharmacy's credentials.
Can my doctor legally prescribe compounded sermorelin?
Yes. Licensed healthcare providers can prescribe compounded medications, including sermorelin, when they determine it's clinically appropriate. This falls under standard prescribing authority and off-label use provisions.
Will sermorelin ever get FDA approval again?
There are no publicly known efforts to bring a new commercially manufactured sermorelin product through the FDA approval process. The compound remains widely available through compounding pharmacies, which reduces the commercial incentive for a manufacturer to pursue new approval.
Make an Informed Choice
Sermorelin occupies a well-supported position in the peptide therapy space. Its FDA approval history, combined with decades of clinical use and a strong compounding framework, provides a solid foundation for patients exploring growth hormone improvement. Our team can help you understand the regulatory details and connect you with quality providers and pharmacies. is sermorelin fda approved
Ready when you are
Sermorelin
Bioidentical GHRH analog for natural growth hormone pulsatility · From $175/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Sermorelin →